FETAX interlaboratory validation study: phase III--Part 1 testing.

FETAX interlaboratory validation study: phase III--Part 1 testing.

Item
http://www.wikidata.org/entity/Q52199197
Aryl hydrocarbon receptors in the frog Xenopus laevis: two AhR1 paralogs exhibit low affinity for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).What's happening to our frogs?Evaluation of Xenopus tropicalis as an alternative test organism for frog embryo teratogenesis assay--Xenopus (FETAX).Background-free in-vivo Imaging of Vitamin C using Time-gateable Responsive ProbeTeratogen screening: state of the art.Exposure to low concentrations of di-n-butyl phthalate during embryogenesis reduces survivability and impairs development of Xenopus laevis frogs.Effect of allyl isothiocyanate on developmental toxicity in exposed Xenopus laevis embryos.Effects of cyanobacterial biomass and purified microcystins on malformations in Xenopus laevis: teratogenesis assay (FETAX).FETAX Assay for Evaluation of Developmental Toxicity.Phase III interlaboratory study of FETAX, Part 2: interlaboratory validation of an exogenous metabolic activation system for frog embryo teratogenesis assay--Xenopus (FETAX).
P2860

FETAX interlaboratory validation study: phase III--Part 1 testing.

Item
http://www.wikidata.org/entity/Q52199197
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
FETAX interlaboratory validation study: phase III--Part 1 testing.
@en
FETAX interlaboratory validation study: phase III--Part 1 testing.
@nl
type
label
FETAX interlaboratory validation study: phase III--Part 1 testing.
@en
FETAX interlaboratory validation study: phase III--Part 1 testing.
@nl
prefLabel
FETAX interlaboratory validation study: phase III--Part 1 testing.
@en
FETAX interlaboratory validation study: phase III--Part 1 testing.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
FETAX interlaboratory validation study: phase III--Part 1 testing.
@en
P2093
P304
P31
P356
10.1002/(SICI)1099-1263(199611)16:6<517::AID-JAT385>3.0.CO;2-R
P407
P433
P478
P577
P698